Chardan Capital Initiates Signal Genetics At Buy

Analysts at Chardan Capital initiated coverage on Signal Genetics Inc (NASDAQ: SGNL) with a Buy rating.

The target price for Signal Genetics is set to $2.50.

Signal Genetics shares have dropped 80.76 percent over the past 52 weeks, while the S&P 500 index has surged 8.87 percent in the same period.

Signal Genetics' shares rose 1.32 percent to close at $1.53 yesterday.